Regulation of genetically engineered (GE) mosquitoes as a public health tool: a public health ethics analysis

Author:

Meghani Zahra

Abstract

Abstract Background In recent years, genetically engineered (GE) mosquitoes have been proposed as a public health measure against the high incidence of mosquito-borne diseases among the poor in regions of the global South. While uncertainties as well as risks for humans and ecosystems are entailed by the open-release of GE mosquitoes, a powerful global health governance non-state organization is funding the development of and advocating the use of those bio-technologies as public health tools. In August 2016, the US Food and Drug Agency (FDA) approved the uncaged field trial of a GE Aedes aegypti mosquito in Key Haven, Florida. The FDA’s decision was based on its assessment of the risks of the proposed experimental public health research project. The FDA is considered a global regulatory standard setter. So, its approval of the uncaged field trial could be used by proponents of GE mosquitoes to urge countries in the global South to permit the use of those bio-technologies. Method From a public health ethics perspective, this paper evaluates the FDA’s 2016 risk assessment of the proposed uncaged field trial of the GE mosquito to determine whether it qualified as a realistic risk evaluation. Results The FDA’s risk assessment of the proposed uncaged field trial did not proximate the conditions under which the GE mosquitoes would be used in regions of the global South where there is a high prevalence of mosquito-borne diseases. Conclusion Given that health and disease have political-economic determinants, whether a risk assessment of a product is realistic or not particularly matters with respect to interventions meant for public health problems that disproportionately impact socio-economically marginalized populations. If ineffective public health interventions are adopted based on risk evaluations that do not closely mirror the conditions under which those products would actually be used, there could be public health and ethical costs for those populations.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference91 articles.

1. Hayes KR, Hosack GR, Dana GV, Foster SD, Ford JH, Thresher R, et al. Identifying and detecting potentially adverse ecological outcomes associated with the release of gene-drive modified organisms. J Responsible Innov. 2018;5(sup1):S139–58 Available at: https://www.tandfonline.com/doi/pdf/10.1080/23299460.2017.1415585.

2. Meghani Z. Autonomy of nations and indigenous peoples and the environmental release of genetically engineered animals with gene drives. Glob Policy. 2019;10(4):554–68 https://doi.org/10.1111/1758-5899.12699.

3. National Academies of Sciences, Engineering, and Medicine (NASEM). Gene drives on the horizon: advancing science, navigating uncertainty, and aligning research with public values: National Academies Press; 2016.

4. US Centers for Disease Control (CDC). Vital signs: illness on the rise: vital signs: illnesses on the rise: from mosquito, tick, and flea bites. May 1, 2018. (Source: Rosenberg R, et al. Trends in Reported Vector-Borne Disease Cases—United States and U.S. Territories, 2004-2016. MMWR Morb Mortal Wkly Rep. Vol. 67, 2018 ). Available at: https://web.archive.org/web/20180823025243/https://www.cdc.gov/vitalsigns/vector-borne/infographic.html

5. World Health Organization (WHO). Neglected tropical diseases. 2012. Available at: https://www.who.int/news-room/q-a-detail/neglected-tropical-diseases.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3